SBUX Research Update — September 18, 2026
Updated Thesis
Starbucks is the world's largest specialty coffee retailer, operating company-owned and licensed coffeehouses across North America, International, and Channel Development segments, with a brand that has historically supported premium pricing and global scale. The business quality is currently strained: revenue declined 1.4% year over year in the most recent quarter, TTM operating margin is 9.4%, TTM net margin is 5.2%, and ROE is negative 24.3% alongside negative shareholders' equity of $7.67 billion and $13.38 billion of long-term debt. The shares trade at $96.67, or 55.77 times trailing earnings, 30.36 times free cash flow, and 22.0 times EV/EBITDA, against a blended fair value estimate of $108.52 that implies 12.3% upside and an analyst consensus target of $120 that implies 24.1% upside.
The investment grade as of this refresh is C — average business quality. Medium-tier business, fair-tier valuation with 12.3% upside to $108.52 fair value.
Key Metrics at a Glance
- Revenue growth: -1.4% year over year
- Net margin: 5.2%
- Fair value upside: +12.3% to our estimate of $109
Current price: $96.67
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Starbucks Corporation remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full SBUX research →](/stocks/SBUX)